Cochlear Limited
CHEOF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1,186 | $1,172 | $1,137 | $1,113 |
| % Growth | 1.2% | 3.1% | 2.1% | – |
| Cost of Goods Sold | $318 | $298 | $276 | $286 |
| Gross Profit | $868 | $874 | $861 | $828 |
| % Margin | 73.2% | 74.6% | 75.7% | 74.3% |
| R&D Expenses | $147 | $144 | $150 | $127 |
| G&A Expenses | $105 | $103 | $111 | $102 |
| SG&A Expenses | $470 | $470 | $466 | $432 |
| Sales & Mktg Exp. | $365 | $367 | $355 | $331 |
| Other Operating Expenses | $0 | -$15 | $25 | $0 |
| Operating Expenses | $617 | $600 | $641 | $559 |
| Operating Income | $251 | $275 | $220 | $268 |
| % Margin | 21.2% | 23.4% | 19.4% | 24.1% |
| Other Income/Exp. Net | -$9 | $2 | $5 | $5 |
| Pre-Tax Income | $242 | $276 | $225 | $260 |
| Tax Expense | $58 | $71 | $59 | $69 |
| Net Income | $184 | $205 | $165 | $191 |
| % Margin | 15.5% | 17.5% | 14.5% | 17.2% |
| EPS | 2.81 | 3.13 | 2.52 | 2.92 |
| % Growth | -10.2% | 24.2% | -13.7% | – |
| EPS Diluted | 2.8 | 3.12 | 2.52 | 2.91 |
| Weighted Avg Shares Out | 65 | 66 | 66 | 66 |
| Weighted Avg Shares Out Dil | 66 | 66 | 66 | 66 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $2 | $0 | $9 |
| Interest Expense | $5 | $0 | $0 | $4 |
| Depreciation & Amortization | $47 | $44 | $2 | $43 |
| EBITDA | $295 | $316 | $252 | $302 |
| % Margin | 24.8% | 26.9% | 22.2% | 27.1% |